कृपया अन्य खोज का प्रयास करें
Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. It is also involved in the research and development of anti-inflammatory effects of psilocybin for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Kyle H. Ambert | - | 2021 | Member of Scientific Advisory Board |
Julia V. Perederiy | - | 2021 | Member of Scientific Advisory Board |
John Molinaro | - | 2022 | Member of Scientific Advisory Board |
Gary R. Harlem | - | 2021 | Member of Scientific Advisory Board |
Viviana Trezza | - | - | Member of Scientific Advisory Board |
William Rascan | 57 | 2012 | President, CEO & Director |
Marvin S. Hausman | 82 | 2020 | Chairman of Scientific Advisory Board |
Jacqueline McConnell | - | 2020 | COO & Director |
Stephen Glazer | - | 2021 | Chief Science Officer & Director |
Derek Lloyd Harry Ivany | 39 | 2023 | Executive Chairman |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है